Predictions from in silico analysis across the NCI-60 panel support previously reported overexpression of RECQ1 in various cancers and indicate RECQ1 expression to be especially significant in tumors of central nervous system origin and melanoma. The gene discussed is RECQL; the disease is melanoma.